Fibrin-polylactide-based tissue-engineered vascular graft in the arterial circulation.

There is a clear clinical requirement for the design and development of living, functional, small-calibre arterial grafts. Here, we investigate the potential use of a small diameter, tissue-engineered artery in a pre-clinical study in the carotid artery position of sheep. Small-calibre ( approximately 5 mm) vascular composite grafts were molded using a fibrin scaffold supported by a poly(L/D)lactide 96/4 (P(L/D)LA 96/4) mesh, and seeded with autologous arterial-derived cells prior to 28 days of dynamic conditioning. Conditioned grafts were subsequently implanted for up to 6 months as interposed carotid artery grafts in the same animals from which the cells were harvested. Explanted grafts (n = 6) were patent in each of the study groups (1 month, 3 months, 6 months), with a significant stenosis in one explant (3 months). There was a complete absence of thrombus formation on the luminal surface of grafts, with no evidence for aneurysm formation or calcification after 6 months in vivo. Histological analyses revealed remodeling of the fibrin scaffold with mature autologous proteins, and excellent cell distribution within the graft wall. Positive vWf and eNOS staining, in addition to scanning electron microscopy, revealed a confluent monolayer of endothelial cells lining the luminal surface of the grafts. The present study demonstrates the successful production and mid-term application of an autologous, fibrin-based small-calibre vascular graft in the arterial circulation, and highlights the potential for the creation of autologous implantable arterial grafts in a number of settings.

[1]  E Bell,et al.  A blood vessel model constructed from collagen and cultured vascular cells. , 1986, Science.

[2]  Y. Imai,et al.  Transplantation of a tissue-engineered pulmonary artery. , 2001, The New England journal of medicine.

[3]  S. Andreadis,et al.  Engineering of fibrin-based functional and implantable small-diameter blood vessels. , 2005, American journal of physiology. Heart and circulatory physiology.

[4]  Alexander M Seifalian,et al.  Current status of prosthetic bypass grafts: a review. , 2005, Journal of biomedical materials research. Part B, Applied biomaterials.

[5]  Andrea Remuzzi,et al.  Vascular Tissue Engineering , 2006, Cell transplantation.

[6]  Narutoshi Hibino,et al.  Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. , 2005, The Journal of thoracic and cardiovascular surgery.

[7]  N. L'Heureux,et al.  Human tissue-engineered blood vessels for adult arterial revascularization , 2007, Nature Medicine.

[8]  S Jockenhoevel,et al.  Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[9]  Thomas Schmitz-Rode,et al.  In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model. , 2009, Tissue engineering. Part A.

[10]  C. M. Agrawal,et al.  Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. , 1996, Biomaterials.

[11]  V. Ellä,et al.  Studies of P(L/D)LA 96/4 non-woven scaffolds and fibres; properties, wettability and cell spreading before and after intrusive treatment methods , 2007, Journal of materials science. Materials in medicine.

[12]  Marcin Maruszewski,et al.  Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study , 2009, The Lancet.

[13]  H. Senoo,et al.  L‐ascorbic acid 2‐phosphate stimulates collagen accumulation, cell proliferation, and formation of a three‐dimensional tissuelike substance by skin fibroblasts , 1989, Journal of cellular physiology.

[14]  C C Canver,et al.  Conduit options in coronary artery bypass surgery. , 1995, Chest.

[15]  A Haverich,et al.  Use of a fibrin preparation in the engineering of a vascular graft model. , 2004, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[16]  Narutoshi Hibino,et al.  Tissue-engineered arterial grafts: long-term results after implantation in a small animal model. , 2009, Journal of pediatric surgery.

[17]  Frederick J. Schoen,et al.  Functional Growth in Tissue-Engineered Living, Vascular Grafts: Follow-Up at 100 Weeks in a Large Animal Model , 2006, Circulation.

[18]  M. R. Jackson,et al.  Fibrin sealants in surgical practice: An overview. , 2001, American journal of surgery.

[19]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[20]  B. Eppley,et al.  Platelet-Rich Plasma: A Review of Biology and Applications in Plastic Surgery , 2006, Plastic and reconstructive surgery.

[21]  M. Sittinger,et al.  Preparation of a pure autologous biodegradable fibrin matrix for tissue engineering , 2000, Medical and Biological Engineering and Computing.

[22]  E. Topol,et al.  Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. , 1996, Circulation.

[23]  Thomas Schmitz-Rode,et al.  Tranexamic acid--an alternative to aprotinin in fibrin-based cardiovascular tissue engineering. , 2009, Tissue engineering. Part A.

[24]  J. H. van Bockel,et al.  Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. , 2004, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[25]  Robert Langer,et al.  New opportunities: the use of nanotechnologies to manipulate and track stem cells. , 2008, Cell stem cell.

[26]  V. Bernhard,et al.  Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. , 1986, Journal of vascular surgery.

[27]  Simon P Hoerstrup,et al.  A new source for cardiovascular tissue engineering: human bone marrow stromal cells. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[28]  Thomas Schmitz-Rode,et al.  Tissue-engineered small-caliber vascular graft based on a novel biodegradable composite fibrin-polylactide scaffold. , 2009, Tissue engineering. Part A.

[29]  R. Frater,et al.  Spontaneous Host Endothellal Growth on Bioprostheses: Influence of Fixation , 1992, Circulation.

[30]  R T Tranquillo,et al.  Fibrin as an alternative biopolymer to type-I collagen for the fabrication of a media equivalent. , 2002, Journal of biomedical materials research.

[31]  Pool Jg,et al.  HIGH-POTENCY ANTIHAEMOPHILIC FACTOR CONCENTRATE PREPARED FROM CRYOGLOBULIN PRECIPITATE. , 1964 .

[32]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.

[33]  B J Messmer,et al.  Fibrin gel -- advantages of a new scaffold in cardiovascular tissue engineering. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[34]  M A Moses,et al.  Tissue engineering of autologous aorta using a new biodegradable polymer. , 1999, The Annals of thoracic surgery.

[35]  R. Sapsford,et al.  Early and late patency of expanded polytetrafluoroethylene vascular grafts in aorta-coronary bypass. , 1981, The Journal of thoracic and cardiovascular surgery.